Literature DB >> 10714687

Murine CD1d-restricted T cell recognition of cellular lipids.

J E Gumperz1, C Roy, A Makowska, D Lum, M Sugita, T Podrebarac, Y Koezuka, S A Porcelli, S Cardell, M B Brenner, S M Behar.   

Abstract

NKT cells are associated with immunological control of autoimmune disease and cancer and can recognize cell surface mCD1d without addition of exogenous antigens. Cellular antigens presented by mCD1d have not been identified, although NKT cells can recognize a synthetic glycolipid, alpha-GalCer. Here we show that after addition of a lipid extract from a tumor cell line, plate-bound mCD1d molecules stimulated an NKT cell hybridoma. This hybridoma also responded strongly to three purified phospholipids, but failed to recognize alpha-GalCer. Seven of sixteen other mCD1d restricted hybridomas also showed a response to certain purified phospholipids. These findings suggest NKT cells can recognize cellular antigens distinct from alpha-GalCer and identify phospholipids as potential self-antigens presented by mCD1d.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10714687     DOI: 10.1016/s1074-7613(00)80174-0

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  183 in total

1.  Requirement for natural killer T (NKT) cells in the induction of allograft tolerance.

Authors:  K I Seino; K Fukao; K Muramoto; K Yanagisawa; Y Takada; S Kakuta; Y Iwakura; L Van Kaer; K Takeda; T Nakayama; M Taniguchi; H Bashuda; H Yagita; K Okumura
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

Review 2.  Immune recognition, response, and regulation: how T lymphocytes do it.

Authors:  S Joyce
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 3.  A new aspect in glycolipid biology: glycosphingolipids as antigens recognized by T lymphocytes.

Authors:  G De Libero; A Donda; H J Gober; V Manolova; Z Mazorra; A Shamshiev; L Mori
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

4.  NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor beta, and by clonally deleting antigen-specific T cells.

Authors:  Hyun Jung Kim; Su Jin Hwang; Byoung Kwon Kim; Kyeong Cheon Jung; Doo Hyun Chung
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

5.  Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus.

Authors:  Defu Zeng; Yinping Liu; Stephane Sidobre; Mitchell Kronenberg; Samuel Strober
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 6.  Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.

Authors:  Aleksandar K Stanic; Jang-June Park; Sebastian Joyce
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

Review 7.  Mechanisms of immune resolution.

Authors:  Alfred Ayala; Chun-Shiang Chung; Patricia S Grutkoski; Grace Y Song
Journal:  Crit Care Med       Date:  2003-08       Impact factor: 7.598

8.  Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell.

Authors:  Joyce Rauch; Jenny Gumperz; Cheryl Robinson; Markus Sköld; Chris Roy; David C Young; Michel Lafleur; D Branch Moody; Michael B Brenner; Catherine E Costello; Samuel M Behar
Journal:  J Biol Chem       Date:  2003-09-08       Impact factor: 5.157

9.  Polymorphisms in CD1d affect antigen presentation and the activation of CD1d-restricted T cells.

Authors:  Michael I Zimmer; Hanh P Nguyen; Bin Wang; Honglin Xu; Angela Colmone; Kyrie Felio; Hak-Jong Choi; Ping Zhou; Maria-Luisa Alegre; Chyung-Ru Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

Review 10.  The role of adenosine signaling in sickle cell therapeutics.

Authors:  Joshua J Field; David G Nathan; Joel Linden
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.